{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:41:12Z","timestamp":1740174072983,"version":"3.37.3"},"reference-count":40,"publisher":"Georg Thieme Verlag KG","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":61,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Proyecto de Cooperaci\u00f3n Bilateral Uruguay- Brasil, Dicyt-CNPq","award":["ANII-FCE-1-2011-1-5997"],"award-info":[{"award-number":["ANII-FCE-1-2011-1-5997"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Science"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.slsci.2016.05.010","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T12:48:42Z","timestamp":1465303722000},"page":"89-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Subchronical treatment with Fluoxetine modifies the activity of the MCHergic and hypocretinergic systems. Evidences from peptide CSF concentration and gene expression"],"prefix":"10.1055","volume":"9","author":[{"given":"Bruno F.","family":"Calegare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Torterolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e2nia D\u2019","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","reference":[{"key":"10.1016\/j.slsci.2016.05.010_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1087-0792(01)90200-X","article-title":"Neurobiological bases for the relation between sleep and depression","volume":"6","author":"Adrien","year":"2002","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.slsci.2016.05.010_bib2","doi-asserted-by":"crossref","unstructured":"American-Psychiatric-Association. Diagnostic and statistical manual of mental disorders. DSM-5, Fifth Ed. Washington DC; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.slsci.2016.05.010_bib3","series-title":"Principles and practices of Sleep Medicine","first-page":"1311","article-title":"Mood disorders","author":"Benca","year":"2005"},{"key":"10.1016\/j.slsci.2016.05.010_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cne.903190204","article-title":"The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization","volume":"319","author":"Bittencourt","year":"1992","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.slsci.2016.05.010_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nm0902-1039b","article-title":"Antidepressant, anxiolytic and anorectic effects of a melanin- concentrating hormone-1 receptor antagonist","volume":"8","author":"Borowsky","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.slsci.2016.05.010_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pbb.2015.05.018","article-title":"Antidepressant\/anxiolytic potential and adverse effect liabilities of melanin-concentrating hormone receptor 1 antagonists in animal models","volume":"135","author":"Chaki","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.slsci.2016.05.010_bib7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1152\/japplphysiol.00700.2012","article-title":"A unified survival theory of the functioning of the hypocretinergic system","volume":"115","author":"Chase","year":"2013","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.slsci.2016.05.010_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1124\/jpet.106.109678","volume":"321","author":"David","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.slsci.2016.05.010_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2014.12.032","article-title":"Melanin-concentrating hormone (MCH) modulates the activity of dorsal raphe neurons","volume":"1598","author":"Devera","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.slsci.2016.05.010_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.peptides.2015.10.001","article-title":"MCH levels in the CSF, brain preproMCH and MCHR1 gene expression during paradoxical sleep deprivation, sleep rebound and chronic sleep restriction","volume":"74","author":"Dias Abdo Agamme","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.slsci.2016.05.010_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.euroneuro.2011.12.001","article-title":"The melanin-concentrating hormone (MCH) system in an animal model of depression-like behavior","volume":"22","author":"Garcia-Fuster","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.slsci.2016.05.010_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/jpet.108.143362","article-title":"Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression","volume":"329","author":"Gehlert","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.slsci.2016.05.010_bib13","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1523\/JNEUROSCI.1714-04.2005","article-title":"The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance","volume":"25","author":"Georgescu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.slsci.2016.05.010_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-013-3046-4","article-title":"Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation","volume":"228","author":"Katai","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.slsci.2016.05.010_bib15","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1176\/ajp.2006.163.9.1561","article-title":"Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers","volume":"163","author":"Kessler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.slsci.2016.05.010_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fnsys.2014.00244","article-title":"Neurons containing orexin or melanin concentrating hormone reciprocally regulate wake and sleep","volume":"8","author":"Konadhode","year":"2015","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.slsci.2016.05.010_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2009.02.010","article-title":"Effects on sleep of melanin-concentrating hormone microinjections into the dorsal raphe nucleus","volume":"1265","author":"Lagos","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.slsci.2016.05.010_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2010.11.027","article-title":"Immunoneutralization of melanin-concentrating hormone (MCH) in the dorsal raphe nucleus: effects on sleep and wakefulness","volume":"1369","author":"Lagos","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.slsci.2016.05.010_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbr.2010.10.035","article-title":"Depressive-like profile induced by MCH microinjections into the dorsal raphe nucleus evaluated in the forced swim test","volume":"218","author":"Lagos","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.slsci.2016.05.010_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.slsci.2016.05.010_bib21","doi-asserted-by":"crossref","first-page":"15455","DOI":"10.1523\/JNEUROSCI.4017-11.2011","article-title":"Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level","volume":"31","author":"McGregor","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.slsci.2016.05.010_bib22","doi-asserted-by":"crossref","unstructured":"C., Menard, G.E., Hodes and S.J., Russo, Pathogenesis of depression: Insights from human and rodent studies, Neuroscience (2015).","DOI":"10.1016\/j.neuroscience.2015.05.053"},{"key":"10.1016\/j.slsci.2016.05.010_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neuropharm.2011.04.022","article-title":"Activation of orexin neurons in dorsomedial\/perifornical hypothalamus and antidepressant reversal in a rodent model of depression","volume":"61","author":"Nollet","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.slsci.2016.05.010_bib24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40263-013-0064-z","article-title":"Role of orexin in the pathophysiology of depression: potential for pharmacological intervention,","volume":"27","author":"Nollet","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.slsci.2016.05.010_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neulet.2014.01.015","article-title":"Effects of ketamine and N-methyl-d-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test","volume":"566","author":"Owolabi","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.slsci.2016.05.010_bib26","doi-asserted-by":"crossref","unstructured":"L., Palagini, C., Baglioni, A., Ciapparelli, A., Gemignani and D., Riemann, REM sleep dysregulation in depression: State of the art, Sleep Med Rev (2013).","DOI":"10.1016\/j.smrv.2012.11.001"},{"key":"10.1016\/j.slsci.2016.05.010_bib27","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.slsci.2016.05.010_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/400_2007_052","article-title":"The melanin-concentrating hormone system and its physiological functions","volume":"46","author":"Saito","year":"2008","journal-title":"Results Probl Cell Differ"},{"key":"10.1016\/j.slsci.2016.05.010_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.slsci.2016.05.010_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jad.2015.03.039","article-title":"Dynamics of melanin-concentrating hormone (MCH) serum levels in major depressive disorder during antidepressant treatment","volume":"180","author":"Schmidt","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.slsci.2016.05.010_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbr.2011.02.044","article-title":"Hcrtr1 and 2 signaling differentially regulates depression-like behaviors","volume":"222","author":"Scott","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.slsci.2016.05.010_bib32","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4088\/JCP.v66n0803","article-title":"Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials","volume":"66","author":"Thase","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.slsci.2016.05.010_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.slsci.2014.07.021","article-title":"The hypocretins (orexins) mediate the \u201cphasic\u201d components of REM sleep: a new hypothesis","volume":"7","author":"Torterolo","year":"2014","journal-title":"Sleep Science"},{"key":"10.1016\/j.slsci.2016.05.010_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2011.00014","article-title":"Melanin-concentrating hormone (MCH): a new sleep factor?","volume":"2","author":"Torterolo","year":"2011","journal-title":"Front Neurol"},{"key":"10.1016\/j.slsci.2016.05.010_bib35","doi-asserted-by":"crossref","unstructured":"P., Torterolo, C., Scorza, P., Lagos, J., Urbanavicius, L., Benedetto, C., Pascovich, X., Lopez Hill, M., Chase And Monti, j., Melanin-concentrating Hormone (MCH): Role in REM (sleep and depression), (Frontiers in Neurology), (in press) (2015).","DOI":"10.3389\/fnins.2015.00475"},{"key":"10.1016\/j.slsci.2016.05.010_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.slsci.2016.05.010_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jchemneu.2015.11.010","article-title":"Melanin-concentrating hormone projections to the dorsal raphe nucleus: An immunofluorescence and in vivo microdialysis study","volume":"72","author":"Urbanavicius","year":"2016","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.slsci.2016.05.010_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/FBP.0000000000000056","article-title":"Pro-depressive effect induced by microinjections of MCH into the dorsal raphe: time-course, dose-dependence, effects on anxiety-related behaviors and reversion by nortriptyline","volume":"25","author":"Urbanavicius","year":"2014","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.slsci.2016.05.010_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0896-6273(04)00251-X","article-title":"Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection","volume":"42","author":"van den Pol","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.slsci.2016.05.010_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/cn400186j","article-title":"Classics in chemical neuroscience: fluoxetine (prozac)","volume":"5","author":"Wenthur","year":"2014","journal-title":"ACS Chem Neurosci"}],"container-title":["Sleep Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1984006316300402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1984006316300402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T15:45:55Z","timestamp":1674661555000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1984006316300402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1984006316300402"],"URL":"https:\/\/doi.org\/10.1016\/j.slsci.2016.05.010","relation":{},"ISSN":["1984-0063"],"issn-type":[{"type":"print","value":"1984-0063"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subchronical treatment with Fluoxetine modifies the activity of the MCHergic and hypocretinergic systems. Evidences from peptide CSF concentration and gene expression","name":"articletitle","label":"Article Title"},{"value":"Sleep Science","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.slsci.2016.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Brazilian Association of Sleep. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}